newsfilter
← Latest News
ACCESS Newswire·

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® moleculesCompanies to leverage Immatics' XPRESIDENT® target discovery platform and Moderna's mRNA